National Hospital CEO Ang Hoey Tiong expressed optimism about the growth of Indonesia’s health care industry during his meeting with Minister of Health of the Republic of Indonesia, Budi Gunadi Sadikin, as part of the CNBC Indonesia Health Summit 2026 on Thursday (8/10). The forum discussed various developments and challenges in Indonesia’s health care sector, including health policies, pharmaceutical and medical device innovation, and strengthening national health resilience.
Ang Hoey Tiong believes that Indonesia has significant room for growth in the health care sector. Advances in medical technology, improvements in health care professionals’ competencies, as well as the strengthening of hospital facilities and services are important foundations for Indonesia to build a health care industry that is increasingly competitive on a global level.
“Indonesia has tremendous potential. With improvements in human resources, technology, and health care facilities, I am optimistic that Indonesian health care services will continue to improve and will even be able to compete with health care services abroad,” said Ang Hoey Tiong.
This optimism is also reflected in the development of health care services at National Hospital. The hospital continues to strengthen its medical facilities and technologies, including CT Scan, a 3 Tesla (3T) MRI, which is among the first of its kind in Southeast Asia, as well as a Biplane Cath Lab to support diagnostic and medical intervention services.
This commitment has also received recognition at the Asia-Pacific level. National Hospital received the Global Health Asia-Pacific 2025 Hospital of the Year award, representing recognition of the quality and development of the health care services it provides.
This optimism is in line with Health Minister Budi Gunadi Sadikin’s view regarding the significant growth potential of Indonesia’s health care sector. On the occasion, Budi stated that Indonesia’s current health expenditure is approximately US$140 per capita per year, still below Malaysia’s approximately US$430 per capita per year.
“If over the next five years we can increase [health expenditure per capita] to the level of Malaysia, our spending will reach that level, two to three times higher than it is today,” said Budi Gunadi Sadikin.
According to Budi, this significant room for growth has the potential not only to improve the quality of health care services for the public, but also to become a driver of national economic growth. “So this is a significant potential that can be translated into economic growth for this country,” Budi added.
Ang Hoey Tiong sees this significant opportunity as momentum for the national health care industry to continuously improve service quality and deliver innovations that address the needs of the public.
“If Indonesia’s health care industry can move forward rapidly, the impact will not only be seen in improved public health, but will also create significant opportunities for the growth of the national health care industry. We are optimistic that Indonesia can build health care services that are increasingly high-quality and competitive,” Ang Hoey Tiong concluded.
Through collaboration among the government, hospitals, health care professionals, pharmaceutical and medical device industries, and other stakeholders, Indonesia has an opportunity to strengthen its national health care ecosystem while enhancing the competitiveness of its health care services at the regional level.